Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05024955

Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States

Understanding Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the U.S.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study better understands the views on shared decision-making among Chinese adults who smoke or who have a spouse who smokes. Lung cancer is the second most common cancer among men and women in the United States and is the number one cause of cancer-related mortality among Asians and Pacific Islanders. Clinicians are recommended to initiate conversations about lung cancer screening with eligible patients, provide information about the benefits and harms, and engage in shared decision-making. However, a patient's cultural background can influence decision-making in many ways. Given this, there is a need to understand the perceptions of shared decision-making among different populations (in this case, Asian populations) in order to inform the design of culturally sensitive decision aids for cancer screening. This study evaluates how Chinese populations in the U.S. who currently smoke or who have partners who smoke perceive the process of shared decision-making, their preferences, the perceived barriers and facilitators, and their perspective on currently-available screening tools.

Detailed description

PRIMARY OBJECTIVES: I. Understand how Chinese populations in the Unites States who currently smoke or who have partners who smoke perceive the process of shared health-related decision-making and their preferences in terms of role involvement, and the barriers to and facilitators of shared decision-making. II. Evaluate current publicly available lung cancer screening tools from the perspective of Chinese adults who smoke or who have partners who smoke. OUTLINE: Participants attend an interview over 45-60 minutes and/or a focus group over 1.5 to 2 hours.

Conditions

Interventions

TypeNameDescription
PROCEDUREDiscussionAttend a focus group
OTHERInterviewAttend interview

Timeline

Start date
2021-07-20
Primary completion
2024-03-08
Completion
2024-03-08
First posted
2021-08-27
Last updated
2024-03-15

Source: ClinicalTrials.gov record NCT05024955. Inclusion in this directory is not an endorsement.